Related Experiment Video
Updated: Aug 19, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
Gram-negative bacterial resistance: evolving patterns and treatment paradigms
1Pulmonary and Critical Care Division, Washington University School of Medicine, St. Louis, Missouri 63110, USA. mkollef@im.wustl.edu
Abstract:
Successful treatment of patients with nosocomial pneumonia depends primarily on providing adequate initial antibiotic treatment in a timely manner, because an inappropriate course is closely associated with increased mortality. Gram-negative bacteria are commonly responsible for nosocomial pneumonia, and the increasing prevalence of drug resistance among these bacteria complicates decision making with regard to treatment with antibiotics. Infections due to Pseudomonas aeruginosa are particularly problematic because of their intrinsic resistance to multiple classes of antibiotics and their ability to acquire adaptive resistance during a therapeutic course. Numerous strategies, including the use of combination therapy followed by de-escalation of antibiotics, have shown promise in the treatment of these serious infections. However, future success in treating nosocomial infections depends on the appropriate and responsible use of antibiotics in the intensive care unit, to ensure that the antibiotics available today maintain their effectiveness in the future.
Insights
Timely antibiotic treatment is crucial for treating nosocomial pneumonia, especially Gram-negative infections. Responsible antibiotic use is vital to preserve future treatment effectiveness against resistant bacteria like Pseudomonas aeruginosa.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Antimicrobial Stewardship
Background:
- Nosocomial pneumonia treatment success hinges on prompt, appropriate antibiotic therapy.
- Gram-negative bacteria, particularly Pseudomonas aeruginosa, are common causes and present significant resistance challenges.
- Increasing antimicrobial resistance complicates empirical treatment decisions and impacts patient mortality.
Purpose of the Study:
- To highlight the critical role of initial antibiotic selection in managing nosocomial pneumonia.
- To discuss the challenges posed by drug-resistant Gram-negative bacteria, including Pseudomonas aeruginosa.
- To emphasize the importance of antimicrobial stewardship for preserving future treatment efficacy.
Main Methods:
- Review of current strategies for treating nosocomial pneumonia.
- Analysis of the impact of antibiotic resistance on treatment outcomes.
- Discussion of combination therapy and de-escalation approaches.
Main Results:
- Inappropriate antibiotic courses are linked to increased mortality in nosocomial pneumonia.
- Pseudomonas aeruginosa infections are particularly difficult due to intrinsic and adaptive resistance.
- Combination therapy followed by de-escalation shows promise in managing these infections.
Conclusions:
- Effective management of nosocomial pneumonia requires timely and adequate initial antibiotic therapy.
- Responsible antibiotic use in intensive care units is essential for combating resistance.
- Preserving the effectiveness of current antibiotics is critical for future patient care.
Related Concept Videos
Development of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
